药物优先级确定了帕诺比诺斯塔特作为转移性肝母细胞瘤患者的量身定制治疗元素
Salih Demir1, Alina Hotes1, Tanja Schmid1
1Department of Pediatric Surgery, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Lindwurmstreet 2a, Munich, 80337, Germany.
Journal of experimental & clinical cancer research : CR
|November 11, 2024
概括
帕诺比诺斯塔特通过抑制MYC.显示在治疗转移性肝母细胞瘤的承诺. 这种基因组脱乙酶抑制剂,当与标准化疗相结合时,为改善患者的治疗结果和肺转移清除提供了一个强大的新策略.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 转移性肝母细胞瘤的治疗依赖于有毒化疗和手术.
- 肺转移仍然是一个挑战,需要改进治疗策略.
研究的目的:
- 确定转移性肝母细胞瘤中泛比诺斯塔特的临床前和生物学理由.
- 确定新的治疗点和药物组合,以改善肺转移的清除.
主要方法:
- 使用患者衍生异种移植平台和体外/体内试验.
- 选已建立的药物,重点是基因素脱乙酶抑制剂.
- 研究了panobinostat抗瘤作用的分子机制.
主要成果:
- 帕诺比诺斯塔特对肝细胞母细胞瘤细胞具有很高的疗效,对非癌细胞的影响最小.
- 帕诺比诺斯塔特通过DUSP1上调抑制MYCcoprotein,诱导生长抑制和亡.
- MYC目标基因核素1的升调预测了对泛基因的反应,并与转移性疾病相关.
- 在低纳米分子度下,泛诺斯塔与西斯普拉丁和多克索鲁比辛 (SIOPEL 4 协议) 协同作用.
结论:
- 帕诺比诺斯塔特抑制MYC是一种新的治疗方法,用于转移性肝细胞瘤.
- 泛比诺斯塔特,特别是在组合疗法中,为管理肺转移提供了有效的策略.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


